| 2.16 0.33 (18.03%) | 08-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.62  |
1-year : | 3.06 |
| Resists | First : | 2.25 |
Second : | 2.62 |
| Pivot price | 1.69 |
|||
| Supports | First : | 1.74 |
Second : | 1.44 |
| MAs | MA(5) : | 1.83 |
MA(20) : | 1.68 |
| MA(100) : | 1.86  |
MA(250) : | 2.75 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 78.1 |
D(3) : | 78.3 |
| RSI | RSI(14): 67.8 |
|||
| 52-week | High : | 7.9 | Low : | 0.97 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CDIO ] has closed above the upper band by 27.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 30% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.25 - 2.26 | 2.26 - 2.27 |
| Low: | 1.93 - 1.94 | 1.94 - 1.95 |
| Close: | 2.14 - 2.16 | 2.16 - 2.17 |
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Fri, 07 Aug 2026
Cardio Diagnostics Holdings, Inc. 2026: Revenue $5.36K, EPS ($0.51) — 10-Q Summary - TradingView
Fri, 07 Aug 2026
Cardio Diagnostics (NASDAQ: CDIO) Q2 2026 shows $5.6M cash and equity funding - Stock Titan
Wed, 05 Aug 2026
CDIO | Cardio Diagnostics Holdings Inc. Executive Compensation - Quiver Quantitative
Wed, 05 Aug 2026
Cardio Diagnostics (NASDAQ: CDIO) plans vote on sizable new stock issuance - Stock Titan
Wed, 05 Aug 2026
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026 - Business Wire
Thu, 23 Jul 2026
Cardio Diagnostics (CDIO) details AI-driven heart disease testing and capital raises - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 2.83e+006 (%) |
| Held by Institutions | 8.3 (%) |
| Shares Short | 15 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.08e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -27 % |
| Return on Assets (ttm) | 950.5 % |
| Return on Equity (ttm) | -44.1 % |
| Qtrly Rev. Growth | 14450 % |
| Gross Profit (p.s.) | 84.9 |
| Sales Per Share | -30.09 |
| EBITDA (p.s.) | 7600.91 |
| Qtrly Earnings Growth | -3.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.08 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 4550 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|